Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hepatitis B infection in China.

¹University Department of Medicine, Queen Mary Hospital, Hong Kong, SAR, China. GKKLau@hkstar.com

Clinics in Liver Disease

|June 2, 2001

Summary

Chronic hepatitis B (HBV) infection poses a significant threat in Asia. Lamivudine offers hope, but further research into combination therapies and its use in preventing HBV reactivation is crucial for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Hepatology international·2019

Same author

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Hepatology international·2019

Same author

Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models.

Hepatology international·2017

Same author

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Hepatology international·2015

Same author

Photochemical properties of CeO2-coated ZnO nanorods.

Journal of nanoscience and nanotechnology·2010

Same author

Cell cycle-dependent expression of potassium channels and cell proliferation in rat mesenchymal stem cells from bone marrow.

Cell proliferation·2007

Area of Science:

Hepatology
Virology
Immunology

Background:

Chronic hepatitis B (HBV) infection is a major public health concern in the Asian-Pacific region.
Lamivudine represents a significant advancement in managing chronic HBV infection, offering improved therapeutic options.

Purpose of the Study:

To investigate the potential of combining lamivudine with other antiviral agents or immunomodulators to enhance treatment efficacy.
To explore the role of lamivudine in preventing HBV reactivation after the cessation of immunosuppressive therapy.

Main Methods:

Literature review and analysis of existing clinical data on lamivudine therapy for chronic HBV.
Exploratory research into novel combination strategies and prophylactic applications of lamivudine.

Main Results:

Lamivudine has demonstrated considerable success in managing chronic HBV infection.
Further investigation is warranted to optimize combination therapies and prophylactic use.

Conclusions:

Lamivudine is a cornerstone in chronic HBV management, but its full potential may be realized through combination therapies.
Exploring lamivudine's role in preventing HBV reactivation is essential for patient care, particularly in immunocompromised individuals.

Related Experiment Videos